Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0514
Source ID: NCT04470063
Associated Drug: Ddo-3055 Tablets
Title: Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Anemia Associated Chronic Kidney Disease
Interventions: DRUG: DDO-3055 tablets|DRUG: Placebo
Outcome Measures: Primary: The incidence and severity of adverse events to assess safety and tolerability., up to 37 days |
Sponsor/Collaborators: Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE1
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2020-11-17
Completion Date: 2021-12-31
Results First Posted:
Last Update Posted: 2021-10-26
Locations: Beijing Friendship Hospital,Capital Medical University, Beijing, Beijing, 100050, China|Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, 400010, China|Sun Yat Sen memorial hospital Sun Yat Sen university, Guangzhou, Guangdong, 510000, China|The First Affiliated Hospital,Sun Yat-sen University, Guangzhou, Guangdong, 510080, China|Shenzhen Second People's Hospital, Shenzhen, Guangdong, 518000, China|Cangzhou People's Hospital, Cangzhou, Henbei, 075000, China|Yichang Central People's Hospital, Yichang, Hubei, 443000, China|Zhongda Hospital Southeast Universtiy, Nanjing, Jiangsu, 210009, China|The Second Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi, 330000, China|Shandong Qianfo Mountain hospital, Jinan, Shandong, 250013, China|The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266555, China|West China Hospital of Sichuan University, Chengdu, Sichuan, 610044, China
URL: https://clinicaltrials.gov/show/NCT04470063